Last update:
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up
Medications news
Medications
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, could safely preserve the ...
38 minutes ago
0
0
Medications
Old drug, in a low dose, safe and effective in preventing progression of type 1 diabetes in children and young people
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published simultaneously in The Lancet shows that a much lower dose than ...
38 minutes ago
0
0
Scientists discover powerful new antibiotic class to tackle deadly superbugs
Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's most dangerous multidrug-resistant ...
5 hours ago
0
80
Smartphone app boosts drug safety reporting in Uganda, trial finds
Results from a new trial published in The Lancet Global Health show that a mobile application, Med Safety, improved the reporting of suspected adverse drug reactions (ADRs) by health care workers in Uganda.
4 hours ago
0
0
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds
The investigational drug elinzanetant significantly reduces hot flashes and night sweats for postmenopausal women, a large, international clinical trial has found.
7 hours ago
0
1
Vitamin D3 concentrations are lowered by a common vitamin D supplement
Taking vitamin D2 might lower the body's levels of the more efficient form of vitamin D, vitamin D3, according to new research from the University of Surrey, John Innes Center and Quadram Institute Bioscience. Many people ...
7 hours ago
0
1
UK dementia patients may be taking antipsychotics for too long
Thousands of people with dementia are prescribed powerful medications for longer and at higher doses than recommended, raising concerns about safety and quality of care, finds a new study led by UCL researchers.
6 hours ago
0
0
Antipsychotic-treated patients with schizophrenia see benefits from semaglutide, study claims
A multicenter collaboration of Danish researchers reports that once-weekly semaglutide for 30 weeks lowered blood sugar levels and body weight and improved physical quality of life in antipsychotic-treated adults with schizophrenia ...
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk of recurrence after surgery ...
Sep 17, 2025
0
101
Study finds orforglipron taken orally once daily leads to significant body weight loss
New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15–19) and simultaneously published in NEJM shows that daily treatment with the new once-daily ...
Sep 17, 2025
0
0
New data sheds light on immunotherapy failure, bringing hope to patients with cancer
A new study by researchers from the University of Birmingham and the University of Turku, Finland has revealed an important clue as to why immunotherapy fails in many patients with cancer.
Sep 17, 2025
0
0
A local anesthetic that doesn't impair motor function could be within reach
All current local anesthetics block sensory signals—pain—but they also interrupt motor signals, which can be problematic. For example, too much epidural anesthesia can prevent mothers in labor from being able to push. ...
Sep 17, 2025
0
0
New drug lowers treatment-resistant high blood pressure and may slow kidney disease
A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for people with hard-to-treat hypertension. The medication, baxdrostat, reduces the levels of a hormone ...
Sep 17, 2025
0
0
Drug used for motor neuron diseases holds promise for spinal cord injury, finds study
A drug called riluzole, commonly used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases, could also assist in recovery from spinal cord injuries, according to research from the University of Toronto's ...
Sep 16, 2025
0
0
'Virtual clinical trials' may predict success of heart failure drugs
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most pressing health challenges. By combining advanced computer modeling with ...
Sep 16, 2025
0
0
A forgotten opioid has resurfaced as a lethal street drug
Nitazenes—a class of highly potent synthetic opioids—are rapidly emerging as a major contributor to the overdose crisis, according to a Pain Medicine review published today by authors from Vanderbilt University Medical ...
Sep 16, 2025
0
2
Beta blockers: Why are celebrities name-checking this drug?
A little blue pill is creating a stir in Hollywood—and no, it's not Viagra. It's propranolol, a beta blocker originally designed for heart conditions, that's now making its way into dressing rooms, award ceremonies and ...
Sep 16, 2025
0
0
Older Australians collect an average of 31 PBS scripts a year—new research
Australians are living longer than ever before. While this is broadly good news, aging well comes with a range of challenges.
Sep 16, 2025
0
0
Challenging negative data helps AI models better identify effective antibodies
Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.
Sep 15, 2025
0
23
About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) shows that some individuals who are taking Ozempic, Wegovy or Mounjaro ...
Sep 15, 2025
0
2
Epilepsy drug's feared fertility risks in men found to be minimal
A large-scale international study led by the University of Liverpool has found little evidence that sodium valproate significantly impairs male fertility in men with epilepsy or bipolar disorder.
Sep 15, 2025
0
0
Taking semaglutide turns down food noise, research suggests
New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) shows that individuals who are taking semaglutide for weight loss experience ...
Sep 15, 2025
0
0
Treatment for rare genetic cause of sudden vision loss approved following clinical trial
A novel treatment for Leber's Hereditary Optic Neuropathy (LHON), a rare genetic disease that can lead to sudden loss of vision, has been approved for NHS patients following a successful clinical trial co-led by UCL and Moorfields ...
Sep 15, 2025
0
0
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public scrutiny.
Sep 15, 2025
0
0
Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm
A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, ...
Sep 14, 2025
0
78
